CMS Web Interface Support Call 2-21-24: 2023 Data Submission
TLDRThe transcript details a support call for the CMS Web Interface, focusing on quality reporting for ACOs. The call covers the submission deadline, interface accessibility, and exclusions and exceptions for measures like DM-2 and PREV-13. Experts clarify requirements, answer FAQs, and provide guidance on reporting and demographic updates. The call emphasizes the importance of accurate data reporting and offers resources for further assistance.
Takeaways
- π The CMS Web Interface will close at 8 PM Eastern Time on April 1, 2024.
- π The sign-in link for the CMS Web Interface is available on the Quality Program Payment Program website.
- π The CMS Web Interface Application Programming Interface (API) is available for testing all year in the developer preview environment.
- π« It's not necessary to request an 'Other CMS-Approved Reason' if there's an applicable denominator exclusion or exception.
- π Requests for an 'Other CMS-Approved Reason' should be submitted early, as those after March 25 may not be processed before the submission period closes.
- π‘ Denominator exclusions and exceptions are two options to remove a patient from the measure or the measure's performance calculation.
- π₯ Documentation of certain medical conditions, like diabetes or hypertension, can be completed during a telehealth encounter.
- π The recording and transcript of the slide deck from the call will be available on the QPP Webinar Library within two weeks.
- π The Quality Payment Program Service Center can answer questions regarding cost, Promoting Interoperability, improvement activities, MIPS, or quality reporting in general.
- π For measures like DM-2 and PREV-13, specific FAQs and exclusion criteria are detailed in the presentation.
- π The last CMS Web Interface Support Call will be on March 6, 2024, covering CARE-2 and MH-1 related measure questions.
Q & A
What is the purpose of the CMS Web Interface Support Call?
-The purpose of the CMS Web Interface Support Call is to provide information on CMS Web Interface quality reporting and to give attendees an opportunity to ask questions related to the topic.
How can CMS Web Interface quality reporting be accessed?
-The CMS Web Interface is accessible using the sign-in link found on the Quality Program Payment Program website.
What is the deadline for the CMS Web Interface submission?
-The CMS Web Interface will close at 8 PM Eastern Time on April 1, 2024.
What is the process for submitting a request to skip patients for the CMS Web Interface?
-Requests to skip patients should be submitted with a CMS-approved reason. It is not necessary to request an 'Other CMS-Approved Reason' if there's an applicable denominator exclusion or exception.
What is the timeline for the recording and transcript of the slide deck to be available?
-The recording and transcript of the slide deck will be available on the QPP Webinar Library within the next two weeks after the call.
What are the two options to remove a patient from a measure or its performance calculation?
-The two options are to exclude a patient from the denominator of a measure (denominator exclusion) or to remove them from the calculation of performance for the measure (denominator exception).
What is the intent of the DM-2 measure?
-The intent of the DM-2 measure is for patients aged 18 to 75 years with diabetes to have a most recent hemoglobin A1c result not greater than 9% during the measurement period.
How can the most recent HbA1c result be documented for the DM-2 measure?
-Documentation of the most recent HbA1c result may be completed during a telehealth encounter and must include a distinct numeric HbA1c result and the date blood was drawn.
What is the guidance for PREV-13 regarding statin therapy for patients at high risk of cardiovascular events?
-The guidance for PREV-13 is that patients considered at high risk of cardiovascular events should be prescribed or taking statin therapy during the measurement period.
How can a patient's statin therapy be documented for the PREV-13 measure?
-Documentation of statin therapy prescribed or being taken during the measurement period can be completed during a telehealth encounter.
What should be done if there is an error in the Web Interface application when trying to change 'No Encounter' values?
-If there is an error when trying to change 'No Encounter' values, the error should be disregarded as long as the intention is to correct the information based on accurate medical records. The correct approach is to amend the Excel file used for data submission and re-upload it.
Outlines
π Introduction and Web Interface Support Call Overview
The video script begins with a welcome message from Ketchum for the Web Interface Support Call. It is followed by Sandra Adams Slaughter from CMS, who introduces the purpose of the call, which is to assist ACOs in preparing for quality reporting. Sandra emphasizes that the call will focus on 2023 CMS Web Interface quality reporting and that a recording of the session will be available in the QPP Webinar Library within two weeks. She also mentions the availability of CMS experts for questions and introduces the next speaker, Kayte Moore.
π Exclusions, Exceptions, and Measure-Specific Questions
Kayte Moore from PIMMS discusses measure-level exclusions and exceptions, clarifying the difference between denominator exclusions and exceptions. She explains how to submit requests for 'Other CMS-Approved Reason' and provides guidance on submitting these requests before the deadline. Kayte then addresses frequently asked questions about specific measures, such as DM-2 and PREV-13, providing detailed answers regarding patient eligibility, documentation requirements, and reporting guidelines.
π‘ Additional Measure Clarifications and Q&A
The session continues with further clarifications on measures and a Q&A segment. Various PIMMS representatives, including Kayte Moore, Deb Kaldenberg, and Carrie Barrows, address questions from attendees regarding the handling of specific scenarios in measures like DM-2, PREV-7, and PREV-10. They provide guidance on documentation, reporting, and the use of the Web Interface for data submission. The representatives also discuss the implications of changes in patient demographics and the process for correcting errors in the system.
π Final Q&A and Closing Remarks
The final part of the video script involves a continuation of the Q&A session, with attendees asking questions about measures like PREV-10 and DM-2. The PIMMS representatives, including Deb Kaldenberg and Jamie Welch, provide detailed answers and guidance. Sandra Adams Slaughter concludes the call by thanking everyone for participating, reminding attendees about the availability of the session recording, and providing information about the last CMS Web Interface Support Call scheduled for March 6, 2024.
Mindmap
Keywords
π‘Web Interface Support Call
π‘CMS
π‘Quality Reporting
π‘ACOs
π‘Q&A Session
π‘Measures
π‘Denominator Exclusions
π‘API
π‘Telehealth Encounter
π‘Service Center
π‘Measure Specifications
Highlights
The presentation will be followed by a Q&A session where attendees can ask questions related to Web Interface Support.
A recording of the slide deck from the call will be posted to the QPP Webinar Library within the next two weeks.
The CMS Web Interface will close at 8 PM Eastern Time on April 1, 2024.
The CMS Web Interface Application Programming Interface (API) is available for testing all year in the developer preview environment.
There is a process for submitting requests to skip patients for CMS-approved reasons.
Requests for an 'Other CMS-Approved Reason' should be submitted early, as those after March 25 may not be processed before the submission period closes.
Measure-level exclusions, exceptions, and frequently asked measure questions were reviewed, including details about the DM-2 measure for diabetes patients.
For the DM-2 measure, patients must have an active diagnosis of diabetes during the measurement period or the year prior to be included.
The 2023 DM-2 Measure Specifications were updated to include all types of diabetes, not just Type 1 or Type 2.
The PREV-13 measure focuses on patients at high risk of cardiovascular events being prescribed or taking statin therapy.
Frequently asked questions about PREV-13, including the use of frailty codes and statin exceptions, were discussed.
Resources and contact information for additional assistance with the CMS Web Interface are available on the Quality Payment Program Resource Library.
The Q&A portion of the webinar allows attendees to ask questions related to the CMS Web Interface and quality reporting.
A clarification was provided regarding the use of frailty codes as denominator exclusions for certain measures.
Instructions on how to properly submit 'Other CMS-Approved Reason' requests and the importance of submitting them early were emphasized.
The webinar provided detailed guidance on how to handle various scenarios related to patient reporting, exclusions, and exceptions in the CMS Web Interface.
Transcripts
Browse More Related Video
WHO: Revision of ICD-11 β questions and answers (Q&A)
Medicaid State Plan Amendment (SPA) Training for State Staff
Forms 1042 and 1042-S: What You Need to Know Before Filing
States push for harsher school discipline practices to address student misbehavior
Child maltreatment: Types of abuse, recognising signs, screening guide and intervention
2023 icd 10cm coding guidelines for chapter 18
5.0 / 5 (0 votes)
Thanks for rating: